Tony GBM is such a vicious disease that patients from cohort 1 probably wont be alive for cohort 4 unfortunately. Have a look at life expectancy. Now these patients have already had SOC fail them.
Any stabile disease or better achieved already is out performing SOC already.
CHM Price at posting:
14.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)